Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant of COVID-19: UK govt study

The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult population in India to protect against the deadly virus.

https://ift.tt/eA8V8J from https://ift.tt/3vNmqr2

ليست هناك تعليقات:

إرسال تعليق

Punjab govt announces Rs 1 crore cash award to India men`s hockey team players from the state

Indian men's hockey team on Thursday morning created history at the Tokyo Olympics by winning a bronze, their first medal in 41 years fr...